Pricing increases more than offset volume declines, which is how Altria Group's revenue net of excise taxes through the first half of this year managed to edge a fraction of a percent higher to $10.19 billion. Along with the robust drug pipeline to support future revenue and earnings, the company's dividend payout ratio is positioned to be a manageable 40.7% in 2022. Genuine Parts Inflation is eating away at discretionary income, and semiconductor chip shortages are contributing to disruptions in new car production.